Research study Program year 2023 Source: CMS Open Payments

AMG 133 Phase 1 FIH

Research payments

$3,447,902

19 payments

Through program year 2023, $3,447,902 in research payments was reported against AMG 133 Phase 1 FIH, across 19 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$300,740	1
2022	Research	$623,220	4
2021	Research	$1,871,897	7
2020	Research	$652,045	7

Breakdown

Who paid Research payments · program years 2020–2023

Amgen Inc. $3,447,902 19 payments

Who received the money Research payments · program years 2020–2023

Orange County Research Center Organisation paid for research $2,171,601 7 payments
Clinical Pharmacology Of Miami, LLC Organisation paid for research $513,674 4 payments
Anaheim Clinical Trials Organisation paid for research $461,733 6 payments
Memorial Research Medical Clinic DBA Orange County Research Center Organisation paid for research $300,740 1 payment
Clinical Pharmacology Of Miami, Ll Organisation paid for research $155 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

4 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.